Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Trial of the Need for Adjuvant Chemotherapy in Stage I Epithelial Ovarian Cancer After Comprehensive Staging Surgery

NCT04063527 is registered in ClinicalTrials.gov with Japanese Gynecologic Oncology Group as lead sponsor.

NCT NCT04063527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04063527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Trial of the Need for Adjuvant Chemotherapy in Stage I Epithelial Ovarian Cancer After Comprehensive Staging Surgery
Lead sponsor
Japanese Gynecologic Oncology Group
Phase
Phase 3
Overall status
Recruiting
Start date
July 20, 2012
Completion date
February 1, 2030
Enrollment
360 (estimated)
Sites
103

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer